Fig. 1From: Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer’s disease using EEG technologyThe schematic diagram of the classification a–d of HC/MCI/AD participants and assessment e–g of participants’ cognitive function and disease progressionBack to article page